SANG vs IPEX
Comparison between SANGSTAT MEDICAL CORP (SANG, Company) and Inflection Point Acquisition Corp V - Class A (IPEX, Company).
SANG is from the Technology sector, while IPEX is from the Financial Services sector.
SANG vs IPEX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
SANG vs IPEX - Historical Returns
Returns include dividend reinvestment.
SANG vs IPEX - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | SANG | IPEX |
|---|---|---|
| 2026 | -27.51% | +1.85% |
| 2025 | -28.71% | +4.15% |
| 2024 | +125.95% | N/A |
| 2023 | -35.48% | N/A |
| 2022 | -74.20% | N/A |
| 2021 | +0.63% | N/A |
SANG vs IPEX Drawdown Comparison
The maximum drawdown for SANG was -87.18%, occurring on Nov 16, 2023. This drawdown has not yet recovered.
The maximum drawdown for IPEX was -1.87%, occurring on Apr 24, 2025. Recovery took 60 trading sessions.
The current SANG drawdown is -80.80%. The current IPEX drawdown is -0.29%.
| Rank | SANG | IPEX |
|---|---|---|
| #1 | -87.18% Jan 3, 2022 - Nov 16, 2023 | -1.87% Apr 22, 2025 - Jul 18, 2025 |
| #2 | -17.01% Dec 9, 2021 - Jan 3, 2022 | -1.34% Oct 20, 2025 - Mar 26, 2026 |
| #3 | N/A | -0.68% Oct 13, 2025 - Oct 20, 2025 |
| #4 | N/A | -0.50% Apr 1, 2025 - Apr 21, 2025 |
| #5 | N/A | -0.49% Jul 31, 2025 - Aug 19, 2025 |
| #6 | N/A | -0.39% Sep 29, 2025 - Oct 8, 2025 |
| #7 | N/A | -0.29% Jun 4, 2026 - Jun 12, 2026 |
| #8 | N/A | -0.24% Sep 16, 2025 - Sep 29, 2025 |
| #9 | N/A | -0.20% Jul 18, 2025 - Jul 28, 2025 |
| #10 | N/A | -0.20% Aug 19, 2025 - Sep 12, 2025 |
| #11 | N/A | -0.10% Mar 10, 2025 - Mar 18, 2025 |
| #12 | N/A | -0.10% Sep 12, 2025 - Sep 16, 2025 |
| #13 | N/A | -0.10% Mar 30, 2026 - Apr 7, 2026 |
| #14 | N/A | -0.10% Apr 7, 2026 - Apr 10, 2026 |
| #15 | N/A | -0.10% Apr 14, 2026 - Apr 27, 2026 |
Correlation
Correlation between SANG and IPEX is -0.66 which considered as a moderate negative correlation - the stocks show some tendency to move in opposite directions.
Select Stocks to Compare
More Comparisons
Compare with similar stocks